首页 工具
登录
购物车

搜索结果

Search Results for " ofatumumab "
Targets Recommended: Others

1

抑制剂 & 化合物

2

重组蛋白

如果没找到您满意的产品或者您对产品有其他要求,可以联系我们专业顾问为您提供针对性的合理建议。     QQ咨询       网站留言咨询

提交您的定制咨询

点击图片重新获取验证码
Cat. No. Product Name Target Signaling Pathways
T9925 Ofatumumab

Others Others
Ofatumumab 是一种人源化靶向抗 CD20单克隆抗体。它作用于表达 CD20 的 B 淋巴细胞,能够诱导产生抗体依赖性细胞介导的细胞毒性和补体依赖性细胞毒性的作用。

化合物

Ofatumumab
Cat.No: T9925
Synonym:
Target: Others
Cat. No. Product Name Species Expression System
TMPK-00183 CD20 Protein, Human, Recombinant (His & Avi)

MS4A2,Ly-44,LEU-16,MS4A1,Bp35,CD20 receptor,CVID5,MS4A-1,B1,...

Human E. coli
B-lymphocyte antigen CD20 or CD20 is an activated-glycosylated phosphoprotein expressed on the surface of all B-cells beginning at the pro-B phase (CD45R , CD117) and progressively increasing in concentration until maturity.CD20 is the target of the monoclonal antibodies rituximab, ocrelizumab, obinutuzumab, ofatumumab, ibritumomab tiuxetan, tositumomab, and ublituximab, which are all active agents in the treatment of all B cell lymphomas, leukemias, and B cell-mediated autoimmune diseases. CD20...
TMPK-00184 CD20 Protein, Human, Recombinant (His & Avi), Biotinylated

MS4A-1,CD20,B-lymphocyte surface antigen B1,Membrane-spannin...

Human E. coli
B-lymphocyte antigen CD20 or CD20 is an activated-glycosylated phosphoprotein expressed on the surface of all B-cells beginning at the pro-B phase (CD45R , CD117) and progressively increasing in concentration until maturity.CD20 is the target of the monoclonal antibodies rituximab, ocrelizumab, obinutuzumab, ofatumumab, ibritumomab tiuxetan, tositumomab, and ublituximab, which are all active agents in the treatment of all B cell lymphomas, leukemias, and B cell-mediated autoimmune diseases. CD20...

重组蛋白

CD20 Protein, Human, Recombinant (His & Avi)
Cat.No: TMPK-00183
Species: Human
Expression System: E. coli
CD20 Protein, Human, Recombinant (His & Avi), Biotinylated
Cat.No: TMPK-00184
Species: Human
Expression System: E. coli
TargetMol Loading
联系我们
400-820-0310

上海市静安区江场三路238号8楼